UBS Group’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.9K | Buy |
48,731
+33,315
| +216% | +$41.6K | ﹤0.01% | 6335 |
|
|
2025
Q1 | $49.8K | Sell |
15,416
-9,510
| -38% | -$30.7K | ﹤0.01% | 6308 |
|
|
2024
Q4 | $103K | Buy |
24,926
+21,122
| +555% | +$87K | ﹤0.01% | 5642 |
|
|
2024
Q3 | $24.4K | Sell |
3,804
-2,127
| -36% | -$13.7K | ﹤0.01% | 6047 |
|
|
2024
Q2 | $28.5K | Buy |
+5,931
| New | +$28.5K | ﹤0.01% | 5943 |
|